电邮这篇文章 Multiple myeloma with monoclonal immunoglobulin A exhibiting and hypercholesterolemia: case report and literature review
- 作者: Livandovskii U.A1, Rybina O.B1
-
隶属关系:
- Moscow State Medical Stomatological University named by A.I.Evdokimova
- 期: 卷 6, 编号 1 (2015)
- 页面: 50-52
- 栏目: Articles
- URL: https://ogarev-online.ru/2221-7185/article/view/45154
- DOI: https://doi.org/10.26442/CS45154
- ID: 45154
如何引用文章
全文:
详细
Multiple myeloma with monoclonal immunoglobulin (Ig) A exhibiting is a type of the classic multiple myeloma, occurring every fifth patient. This type of disorder is associated with hypercholesterolemia that is refractory to the conventional therapy with anti-hyperlipidemic agents.This article presents a case of a patient B., 72 years old, whose disease debuted with high numbers of ESR and hypercholesterolemia. Ig Ak was identified by immunochemical analysis. Patient was diagnosed as having stage IA IgAk type multiple myeloma, diffuse lobular shape, with hyperlipidemia. Positive effect sustained after three courses of chemotherapy: level of IgA eventually subsided, and lipid metabolism returned to normal values.
作者简介
U. Livandovskii
Moscow State Medical Stomatological University named by A.I.Evdokimovaоц. каф. терапии и семейной медицины ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaya, d. 20, str. 1
O. Rybina
Moscow State Medical Stomatological University named by A.I.Evdokimova
Email: Fishka 321@rambler.ru
студент 6-го курса лечебного факультета ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaya, d. 20, str. 1
参考
- Vander-Wall K, Daniels-Wells T.R, Penichet M, Lichtenstein A. Iron in multiple myeloma. Crit Rev Oncog 2013; 18 (5): 449-61.
- Bahlis N, Lazarus H. Multiple myeloma - associated AL amyloidosis: is a distinctive therapeutic approach warranted? Bone Marrow Transplant 2006; 38: 7-15.
- Chou T. Multiple myeloma: recent progress in diagnosis and treatment. J Clin Exp Hematop 2012; 52 (3): 149-59.
- Бессмельцев С.С. Множественная миелома (патогенез, клиника, диагностика, дифференциальный диагноз). Ч. 1. Клин. онкогематология. 2013; 3: 237-57.
- Fukudome K, Kato J, Ohashi T et al. Hyperlipidemia associated with multiple myeloma. Int Med 1996; 35 (4): 337-40.
- Liberopoulos E, Florentin M, Siamopoulos K, Elisaf M. A patient with new - onset hypercholesterolemia. J Clin Lipidol 2009; 3 (2): 143-5.
- Yavasoglu I, Tombuloglu M, Kadikoylu G et al. Cholesterol levels in patients with multiple myeloma. Ann Hematol 2008; 87 (3): 223-8.
- Burnside N, Alberta L, Robinson-Bostom L, Bostom A. Type III hyperlipoproteinemia with xanthomas and multiple myeloma. Am Acad Dermatol 2005; 53 (5 Suppl. 1): S281-4.
- Kilgore L, Patterson B, Parenti D, Fisher W. Immune complex hyperlipidemia induced by an apolipoprotein - reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin. J Clin Invest 1985; 76 (1): 225-32.
- Ming E. IgA type multiple myeloma associated with severe mixed type hyperlipidemia: one case report and literature review[J]. Leuk Lymphoma 2007; 16 (5): 341-3.
- Nozaki S, Ito Y, Nakagawa T et al. Autoimmune hyperlipidemia with inhibitory monoclonal antibodies against low density lipoprotein binding to fibroblasts in a case with multiple myeloma. Int Med 1997; 36 (12): 920-5.
- Shea E, Cohen M. Immunologic detection and measurement of glycated apolipoprotein B with site specific monoclonal antibodies. J Immunol Methods 1993; 162 (1): 85-95.
补充文件
